Michael Hofmann Dr

1 month ago | mondaq.com | Francesco Carloni |Giovanni Campi |Nikolaos Peristerakis |Michael Hofmann Dr

On 14 January 2025, the French Competition Authority(Autorité de la concurrence, FCA) launched a public consultation on the introduction of anew merger control framework aimed at addressing below-thresholdtransactions that could harm competition in France. The FCA's initiative follows the Illumina/Grail judgmentissued by the Court of Justice of the European Union (CJEU) on 3September 2024.

2 months ago | mondaq.com | Francesco Carloni |Giovanni Campi |Nikolaos Peristerakis |Michael Hofmann Dr

European Commission Imposes a Total Fine of €5.7Million for Restricting Cross-Border SalesOn 28 November 2024, the European Commission imposed a totalfine of €5,737,000 million on a company active in the fashionindustry and its largest licensee for breaching Article 101(1) ofthe Treaty on the Functioning of the European Union by restrictingcross-border sales of the fashion brand's products, as well assales of such products to specific customer.

Sep 4, 2024 | mondaq.com | Francesco Carloni |Giovanni Campi |Nikolaos Peristerakis |Michael Hofmann Dr

KG K&L Gates More At K&L Gates, we foster an inclusive and collaborative environment across our fully integrated global platform that enables us to diligently combine the knowledge and expertise of our lawyers and policy professionals to create teams that provide exceptional client solutions.

Jul 26, 2024 | mondaq.com | Francesco Carloni |Giovanni Campi |Nikolaos Peristerakis |Michael Hofmann Dr

On 24 May 2024, the EU Commissioner for Competition, Margrethe Vestager, announced that the European Commission (Commission) will conduct a fact-finding exercise on territorial supply constraints (TSCs). The Commission's announcement follows a request coming from eight Member States, i.e., Belgium, Croatia, Czech Republic, Denmark, Greece, Luxembourg, the Netherlands, and Slovakia.

Jun 7, 2024 | mondaq.com | Francesco Carloni |Giovanni Campi |Nikolaos Peristerakis |Michael Hofmann Dr

On 12 April 2024, the European Commission (Commission) approved the plan to unwind a transaction in the early cancer detection sector that was implemented before securing clearance and subsequently prohibited in 2022 by the Commission.